Syngene International Ltd.

SYNGENE

₹735.7

1.53% (11.1)

Market Cap

₹29,178 Cr.

P/E

58.18

About

Syngene International Limited, founded in 1993, is a globally recognized contract research and manufacturing firm. It offers a wide range of services supporting research and development projects, from… Read more

Syngene International Limited, founded in 1993, is a globally recognized contract research and… Read more

Low

608

52W Range

High

961

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

11 Yes

Positive for this company

1 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Revenue Recognition

Company is converting accounting profit to cash
Depreciation Effect

Company is depreciating a greater percentage of assets. this is contributing to a reduction in net profit
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance
Promoter Holding

Promoters has been selling shares in the open market over last 90 days

Price & Performance

Capex vs ROCE

Roce of the company has increased over the last three years
ROE

Asset turnover is responsible for roe increase over last 10 years
Working Capital

Working capital of the company seems to be under control
Current vs Historic Valuation

Company is trading at a discount to 3yr historic valuations
Debt

Company should not have issues servicing its debt
Sales Growth

Sales of the company has grown at a good pace
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Share price

Share price has increased over last 10 years but more due to rerating
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Peer Comparison

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

Suppliers

HLE Glascoat Ltd.

Customers

Procter & Gamble Health Ltd.
Amgen
Bristol-Myers Squibb
Abbvie
Albireo
Asceneuron SA
FMC Corporation
Genmab A/S
Hindustan Unilever Ltd.
Johnson & Johnson
Rodin Therapeutics Inc.
Sosei Heptares
Zoetis Inc.

Showing 5 of 13

FAQs on Syngene International Ltd. Business

What does Syngene Internation. do?

Syngene International Limited, established in 1993, is a renowned CRMO offering integrated drug discovery and development services. With various certifications and accreditations, the company provides support from lead generation to clinical supplies.

Who are the competitors of Syngene Internation.?

Syngene Internation. major competitors are Piramal Pharma, Laurus Labs, Sun Pharma Adv. Res, Dishman Carbogen Amc, Zenotech Laboratorie, Vivo Bio Tech, Jeevan Scientific.
Market Cap of Syngene Internation. is ₹29,178 Crs.
While the median market cap of its peers are ₹3,304 Crs.

Is Syngene Internation. financially stable compared to its competitors?

Syngene Internation. seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

View FAQ's On Shareprice

Cash Flow Machines

Actual Cash profits are more important than accounting profits. List of companies spitting out cash profits

Run Query

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release		Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec		Jun Dec
Investor Presentation	Mar	Jun Sep Dec	Mar Jun Sep Dec	Mar Apr Jun Jul Sep Dec	Jan Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Jun Sep Dec
Conference Call		Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Sep Dec
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Syngene International Ltd.

Synegene -- A Hidden Platform ? - SOIC

Syngene - A Giant In The Making - MJK Investments

View the discussion on ValuePickr

Least Understood Fact About Syngene By Aditya Khemka - Wealth Podcast

Detailed Analysis on the business of Syngene International - India’s largest listed CRO - Value Educator

Jubilant vs Syngene in CDMO - UnseenValue

Pharmaceutical Sector

How The Pharma Industry Works - PPFAS

Deep Dive into Pharma Sector - Omkara Capital

Pharma Compliance In-Depth - Amit Rajan

Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar

Nutraceuticals- Industry Overview - Value Educator

Generic Opportunity for Indian Pharma Companies - Anish Moonka

Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Syngene International Ltd.